Proto Labs Inc (PRLB): Today's Featured Industrial Goods Laggard
(
) pushed the Industrial Goods sector lower today making it today's featured Industrial Goods laggard. The sector as a whole closed the day up 1.3%. By the end of trading, Proto Labs fell $0.76 (-1.2%) to $63.38 on light volume. Throughout the day, 405,722 shares of Proto Labs exchanged hands as compared to its average daily volume of 556,300 shares. The stock ranged in price between $63.10-$64.97 after having opened the day at $64.90 as compared to the previous trading day's close of $64.14. Other companies within the Industrial Goods sector that declined today were:
(
), down 10.6%,
(
), down 9.7%,
(
), down 6.8% and
(
), down 6.4%.
Proto Labs, Inc. produces CNC machined and injection molded plastic parts. Proto Labs has a market cap of $1.7 billion and is part of the industrial industry. Shares are up 62.7% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate Proto Labs a buy, no analysts rate it a sell, and 3 rate it a hold.
TheStreet Ratings rates
Proto Labs
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the stock itself is trading at a premium valuation.
- You can view the full Proto Labs Ratings Report.
On the positive front,
China Recycling Energy Corporation
(
), up 16.2%,
(
), up 11.1%,
(
), up 9.6% and
(
), up 9.4% , were all gainers within the industrial goods sector with
(
) being today's featured industrial goods sector leader.
- Use our industrial goods section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the industrial goods sector could consider
(
) while those bearish on the industrial goods sector could consider
(
).
- Find other investment ideas from our top rated ETFs lists.
null